Basic information |
Metabolite name | Benzoic acid |
HMDB0001870 | |
C00180 | |
243 | |
Synonyms | Benzamide; |
No. of studies | 14 |
Relationship between Benzoic acid and depression (count: 14) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M067 | Type1 | naturally-occurring depression group vs. control group | Serum | Cynomolgus monkey | Up |
Study M092 | Type1 | LPS group vs. control group | Prefrontal cortex | CD-1 mouse | Up |
Study M098 | Type1 | depressed group vs. control group | Peripheral blood mononuclear cell | Human | Up |
Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | DG region of hippocampus | ICR mouse | Up |
Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA1 region of hippocampus | ICR mouse | Up |
Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Down |
Study M1097 | Type2 | probiotic-treated depression group vs. placebo-treated depression group | Faece | Human | Down |
Study M110 | Type1 | SD group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
Study M547 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
Study M604 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
Study M608 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
Study M608 | Type2 | CUMS + Poria cocos group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
Study M774 | Type1 | MDD group vs. control group | Serum | Human | Up |
Study M840 | Type1 | A1/A2 beta-casein group vs. control group | Urine | Wistar rat | Down |
Study M882 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Down |
Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Up |